Weekly semaglutide injectionCompounded GLP-1Provider profile
Oak Longevity
US telehealth for clinician-reviewed GLP-1 weight-loss care, with monthly and three-month options and no separate membership fee.
Published options
Treatments and prices
GLP-1 weight loss
Compare category →
Weekly semaglutide injectionCompounded GLP-1
Daily oral treatmentOral Semaglutide
Weekly tirzepatide injectionCompounded GIP/GLP-1
Weekly injectionMounjaro®
Weekly injectionOzempic®
Weekly injectionZepbound®
Weekly injectionWegovy®Evidence snapshot
Why this provider is listed
Verified telehealth signals
- Licensed US medical providers
- State-licensed US pharmacies
- Published pricing details available
- US-only program · state availability applies
- Real medical oversight (consult required)
Oak's lowest public semaglutide and tirzepatide figures are current new-patient offers. Confirm the continuing price, exact medication, supply length, and refund terms before you pay.
The Katalys program lists service in all 50 states. Final access depends on clinician approval, state rules, and medication availability.
How it works
- 1
Complete the intake
Provide your health history, identity information, and treatment goal in the online visit.
- 2
Get a physician review
An affiliated physician reviews the information and decides whether treatment is appropriate.
- 3
Choose the supply
Select an available monthly or three-month option after the clinical decision.
- 4
Receive the medication
An approved prescription is filled and shipped to the patient.
Strengths
- ✓ The site publishes current new-patient prices for compounded semaglutide and tirzepatide
- ✓ There is no separate membership fee
- ✓ Monthly orders do not use automatic recurring billing
- ✓ The Katalys program lists all-state service
Watch-outs
- — The lowest public figures are new-patient offers, not verified continuing prices
- — Three-month prescriptions are billed in advance
- — Oak states that shipped medication is not refundable after physician approval
- — Compounded medications are not FDA-approved drug products
Current offer
Current Oak Longevity partner access
No PeptidePrices code is required. The tracked link opens Oak's weight-loss intake. Oak currently advertises new-patient semaglutide from $119 and tirzepatide from $185.
Independent comparison. PeptidePrices may earn a referral fee when you start a plan through these links; this doesn't affect what you pay.
Not medical advice. Prescriptions are issued at a licensed provider's discretion and results vary. Compounded medications are not FDA-approved. PeptidePrices is not a pharmacy, provider, or manufacturer.
